Detalhe da pesquisa
1.
Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort study.
Lancet Oncol
; 25(3): 400-410, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423052
2.
Immune-checkpoint inhibitors in pituitary malignancies.
Anticancer Drugs
; 33(1): e28-e35, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348358
3.
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lancet Oncol
; 21(6): e317-e329, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32502458
4.
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lancet Oncol
; 21(6): e305-e316, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32502457
5.
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Lancet Oncol
; 21(11): 1455-1464, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152285
6.
Lomustine and Bevacizumab in Progressive Glioblastoma.
N Engl J Med
; 377(20): 1954-1963, 2017 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29141164
7.
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.
N Engl J Med
; 376(11): 1027-1037, 2017 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28296618
8.
Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients.
J Neurooncol
; 149(1): 65-71, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32632894
9.
Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy.
Future Oncol
; 16(20): 1433-1439, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32437242
10.
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma.
Lancet Oncol
; 20(12): e715-e728, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31797797
11.
A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma.
Oncologist
; 24(4): 521-528, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30266892
12.
Postsurgical Approaches in Low-Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option?
Oncologist
; 24(5): 664-670, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30777895
13.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
BMC Med
; 17(1): 207, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31747948
14.
Medulloblastoma and central nervous system germ cell tumors in adults: is pediatric experience applicable?
Childs Nerv Syst
; 35(12): 2279-2287, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31414168
15.
The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.
Acta Neuropathol
; 135(4): 601-615, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29368212
16.
Third-line therapy in recurrent glioblastoma: is it another chance for bevacizumab?
J Neurooncol
; 139(2): 383-388, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29671196
17.
Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study.
J Neurooncol
; 136(1): 221-222, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29124650
18.
Temozolomide rechallenge in recurrent glioblastoma: when is it useful?
Future Oncol
; 14(11): 1063-1069, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29741106
19.
The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?
Future Oncol
; 14(16): 1559-1567, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29938525
20.
Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications.
Oncologist
; 22(4): 432-437, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28275120